#2;DESIRED-ISOMER;N-[6-((6-((BIOTINOYL)-AMINO)-HEXANOYL)-CYSTEINE-METHYLESTER-[S-(E,E)-3,7-DIMETHYL-2,6-OCTADIENE-8-[(E)-4-N-(2-DIAZO-3,3,3-TRIFLUOROPROPIONAMI
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 2bUzEi7o2z8 |
|---|---|
| InChI | InChI=1S/C39H61F3N8O7S2/c1-26(13-12-14-27(2)46-23-30(51)36(50-43)39(40,41)42)19-22-58-24-29(37(55)57-3)47-34(54)18-7-5-11-21-44-32(52)16-6-4-10-20-45-33(53)17-9-8-15-31-35-28(25-59-31)48-38(56)49-35/h14,19,28-29,31,35,46H,4-13,15-18,20-25H2,1-3H3,(H,44,52)(H,45,53)(H,47,54)(H2,48,49,56)/b26-19+,27-14+/t28-,29-,31-,35-/m0/s1 |
| InChIKey | AXVYGGDKOSAYRV-KMPQASGOSA-N |
| Mol Weight | 875.1 g/mol |
| Molecular Formula | C39H61F3N8O7S2 |
| Exact Mass | 874.405673 g/mol |
| Enantiomer InChIKey | AXVYGGDKOSAYRV-ZTGUPQNKSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
BIOTINYL-AMINOCAPROYL-GLYCYL-(S-PALMITOYL)-L-CYSTEINE-ALLYLESTER;BIOTACAGLYCYS(PAL)OALL
#8;ETHYL-(4-NITROPHENYL)-(11-[(2-[(2-[6-(5-[(3AR,4R,6AS)-2-OXOPERHYDROTHIENO-[3,4-D]-IMIDAZOL-4-YL]-PENTANOYLAMINO)-HEXANOYL]-AMINOETHYL)-DISULFANYL]-ETHYLAMIN
N-[4-(4-METHOXYTRITYL-AMINOMETHYL)-BENZYL]-BIOTINYLAMIDE
Glycine, N-[N-[N-[3-[(2-decanamidoethyl)thio]-N-decanoyl-L-alanyl]-3-phenyl-L-alanyl]-L-leucyl]-, methyl ester
Propyl 2-[(2,2,3,3,4,4,4-heptafluorobutanoyl)amino]-3-[(2,2,3,3,4,4,4-heptafluorobutanoyl)sulfanyl]propanoate
N2-[4-[[(Benzyloxy)carbonyl)methylamino]benzoyl]-N5-[(1,1,dimethylethoy)carbonyl]-DL-4,4,difluoroornithine tert-Butyl ester
l-Tryptophan, N-[N-(1-oxodecyl)-.beta.-alanyl]-, methyl ester
Dimethyl 1,2,3,4-tetrahydro-6-phenylpyridine-2,5-dicarboxylate
6-Benzyl-2,3-dihydro-5-methylfuro[2,3-c]pyridin-7(6H)-one
(5-HYDROXYL-5-PERFLUOROACETYL-2-OXO-3-OXAPENTYL)-BENZYL-DIMETHYL-AMMONIUM-BROMIDE
| Title | Journal or Book | Year |
|---|---|---|
| Diazotrifluoropropionamido-Containing Prenylcysteines: Syntheses and Applications for Studying Isoprenoid−Protein Interactions | Organic Letters | 2003 |